Healthcare -
Biotechnology - NASDAQ - US
$ 0.6773
5.8 %
$ 61.3 M
Market Cap
-0.37
P/E
VRCA - STOCK-BASED COMPENSATION
Stock-based Compensation VRCA - Verrica Pharmaceuticals Inc.
14.4 M
LAST VALUE
54.11%
2 YEAR CAGR
44.89%
5 YEAR CAGR
0.00%
10 YEAR CAGR